EGFR and non-small cell lung carcinoma: Since i) a correlation between an increased EGFR copy number and gefitinib was proposed in non-small-cell lung cancer (NSCLC) [96] and ii) immunohistochemistry is not a reliable approach for this determination, we decided to evaluate EGFR amplification status in our series by FISH.